Wolverine Asset Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Wolverine Asset Management’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-65,000	Closed	-$677K	–	1759
2019 Q4	$677K	Hold	65,000	–	–	0.01%	710
2019 Q3	$255K	Hold	65,000	–	–	﹤0.01%	949
2019 Q2	$966K	Sell	65,000 -25,000	-28%	-$452K	0.01%	666
2019 Q1	$2.23M	Buy	90,000 +85,000	+1,700%	+$2.13M	0.03%	392
2018 Q4	$89K	Hold	5,000	–	–	﹤0.01%	1371
2018 Q3	$146K	Hold	5,000	–	–	﹤0.01%	1232
2018 Q2	$227K	Buy	+5,000	New	+$243K	﹤0.01%	1089
2017 Q3	–	Sell	-600	Closed	-$56K	–	1535
2017 Q2	$56K	Buy	+600	New	+$36.7K	﹤0.01%	1111

Other funds holding CLVS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

CAS

Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return

CASC

Coppell Advisory Solutions Corp Coppell, Texas $531M AUM

STB

S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

FFWM

Future Financial Wealth Management Cincinnati, Ohio $160M AUM 21.24% 1-Year Est. Return

NFSG

Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Wolverine Asset Management's CLVS Position: Q4 2022 in Review

Wolverine Asset Management sold out of Clovis Oncology, Inc. (CLVS) in Q4 2022, closing a stake of 40,516 shares — an estimated $48K sold.

Wolverine Asset Management first reported a position in CLVS in Q2 2016 and held it in 14 quarters. The position peaked at $1.56M in Q1 2020. 15 funds tracked by Wall St. Rank hold CLVS as of Q4 2022.

Wolverine Asset Management reported no remaining Clovis Oncology, Inc. position as of Q4 2022 after selling out during the quarter.
Wolverine Asset Management sold 40,516 Clovis Oncology, Inc. shares in Q4 2022, an estimated $48K.
Wolverine Asset Management first reported a position in Clovis Oncology, Inc. in Q2 2016 and held it in 14 quarters.
Wolverine Asset Management's Clovis Oncology, Inc. position peaked at $1.56M in Q1 2020.
15 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2022.

Based on Wolverine Asset Management's 13F filing for Q4 2022, filed 1 Feb 2023.